3 Undervalued Advanced Medical Equipment & Technology Stocks for Wednesday, September 27
Discover the top 3 undervalued Advanced Medical Equipment & Technology stocks for Wednesday, September 27 based on AAII’s Stock Grades.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Pratham Shah
Jenna Brashear
Grace Malone
Jack Gilleland
| Share Statistics | MDRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $783.3 | $296.9 | 42% |
|
| Shares Out (Mil) | 128.9 | 52.9 | 67% |
|
| Institutional Ownership | 90.5% | 79.7% | 58% |
|
| Float (Mil) | 126.9 | 44.4 | 66% |
|
| Beta | 0.54 | 1.21 | 31% |
|
| Avg Daily Volume (000s) | 80 | 294 | 34% |
|
| Price Change (52-week) |
(5.2%) | 47.9% | 44% |
|
| Growth | MDRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (18.3%) | 12.8% | 3% |
|
| Net Income (5yr) | (9.9%) | 5.4% | 29% |
|
| EPS (5yr) | (19.8%) | 15.5% | 13 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (38.2%) | (15.5%) | 12% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | MDRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $594 | $192 | 43% |
|
| Net Income (TTM) (Mil) | ($292) | ($9) | 5% |
|
| EPS (TTM) | ($2.695) | ($0.500) | 12% |
|
| Operating Cash Flow (TTM) (Mil) | ($20) | $9 | 15% |
|
| Net Cash Flow (TTM) (Mil) | $286 | $3 | 87% |
|
| Long-Term Debt (Q1) (Mil) | $213 | $16 | 51% |
|
| Enterprise Value (Q1) (Mil) | $282 | $239 | 29% |
|
| Valuation | MDRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.43 | 1.23 | 7% |
|
| P/E | na | 40.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.4 | na |
|
| Ratios | MDRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 50.8% | 61.6% | 63% |
|
| Net Margin | (49.0%) | (22.6%) | 12% |
|
| ROA | (14.0%) | (17.9%) | 23% |
|
| ROE | (22.5%) | (2.1%) | 22% |
|
| Liabilities to Assets | 30.4% | 31.9% | 22% |
|
| F-Score | 6 | 4 | 67% |
|
Veradigm Inc. did not pass any screens on 9/11/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors